General Information

Stock Quote

ABMD (Common Stock)
Exchange NASDAQ (US Dollar)
Price   $75.10
Change (%)   Stock is Down  0.52  (0.69%)
Volume   65,000
Data as of 07/30/15 9:54 AM ET
Minimum 20 minute delay
Refresh quote

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

More>>

More »   Recent News

Date Title  
07/14/15

DANVERS, Mass. - July 14, 2015 - Abiomed, Inc. (NASDAQ: ABMD) announced today that on Tuesday, August 4, 2015, the Company will release financial results for the first quarter of fiscal 2016. The Company will host a conference call to discuss the results on Tuesday, August 4, 2015, at 8:00 a.m....

06/29/15

DANVERS, Mass., June 29, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that it h...

06/04/15

DANVERS, Mass., June 4, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc.(Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and CEO, will present at the William Blair Growth Stock Conference on Wednesday, June 10, 2015 at 10:00 a.m. CDT. The conference will be held at the ...

06/01/15

DANVERS, Mass., June 1, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert Bowen, the Company's Vice President and Chief Financial Officer since 2008, who will celebrate his 66th birthday this summer will retire from Abiomed next month and that Michael Tom...

06/01/15

DANVERS, Mass., June 1, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and CEO, will present at the Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, 2015 at 2:00 p.m. ET. The conference will be held at ...